Literature DB >> 18256093

A total hip replacement infected with mycobacterium bovis after intravesicular treatment with Bacille-Calmette-Guérin for bladder cancer.

O Reigstad1, P Siewers.   

Abstract

An 86-year-old male presented with a loose total hip replacement (THR) ten years after implantation. At revision for anticipated aseptic loosening, watery pus was found in the joint and Bacille-Calmette-Guérin (BCG) was seen on culture. The bacterial strain was identified and was identical to the BCG used in the intravesicular treatment of superficial bladder carcinoma in this patient ten months earlier. After revision he received a full course of antituberculous treatment. The clinical and radiological results were excellent after follow-up for 30 months with his uncemented THR showing satisfactory incorporation. His inflammatory markers were normal and his Harris hip score was 95 points. The diagnosis of a tuberculous infection can be easily missed, but must be considered, especially if sterile pus is encountered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256093     DOI: 10.1302/0301-620X.90B2.20038

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  7 in total

1.  Prosthetic joint infection of the hip and knee due to Mycobacterium species: A systematic review.

Authors:  Asep Santoso; Krisna Yuarno Phatama; Sholahuddin Rhatomy; Nicolaas Cyrillus Budhiparama
Journal:  World J Orthop       Date:  2022-05-18

2.  Myobacterium bovis peri-prosthetic hip infection with successful prosthesis retention following intravesical BCG therapy for bladder carcinoma.

Authors:  Lucy Ping Aitchison; Viran Jayanetti; Steven T Lindstrom; Ronald Sekel
Journal:  Australas Med J       Date:  2015-10-31

3.  Mycobacterium bovis prosthetic joint infection following intravesical instillation of BCG for bladder cancer.

Authors:  Ashka Patel; Joel Elzweig
Journal:  BMJ Case Rep       Date:  2019-12-18

Review 4.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

5.  Prosthetic hip joint infection by Bacillus Calmette-Guerin therapy following intravesical instillation for bladder cancer identified using whole-genome sequencing: a case report.

Authors:  Michael Riste; Pretin Davda; E Grace Smith; David H Wyllie; Martin Dedicoat; Simantini Jog; Steven Laird; Gerald Langman; Neil Jenkins; Jonathan Stevenson; Matthew K O'Shea
Journal:  BMC Infect Dis       Date:  2021-02-05       Impact factor: 3.090

6.  Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG).

Authors:  Eric Gomez; Tom Chiang; Ted Louie; Madhavi Ponnapalli; Robert Eng; David B Huang
Journal:  Int J Microbiol       Date:  2009-12-16

7.  Mycobacterium bovis infection of total hip arthroplasty after intravesicular Bacillus Calmette-Guérin.

Authors:  Ariane Williams; Brendan Arnold; David P Gwynne-Jones
Journal:  Arthroplast Today       Date:  2019-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.